This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001
CS-003
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Decipher Genomic Classifier
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
WCET 2024
SUPS 2024
BCAN TT 2024
SNMMI 2024
ASCO 2024
AUA 2024
All Conferences
View All
PCF
UroToday Home
Conference Highlights
ASCO 2024
ASCO 2024 Bladder Cancer
Conferences
ASCO 2024
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testicular and Penile Cancer
Upper Tract Urothelial Carcinoma
Press Releases
ASCO 2024 Bladder Cancer
Viewing 201-220 of 344 articles
AUA 2017: Efficacy And Safety of Radium-223 By Radical Local Therapy at Initial Diagnosis: A Retrospective Subgroup Analysis of Alsympca Trial
AUA 2017: Trends In Management Of Bone Health In Men With Metastatic Prostate Cancer: Analysis From The Surveillance, Epidemiology, And End Results Medicare Database
AUA 2017: Impact Of Abiraterone Acetate In The Post-docetaxel Setting On The Survival Of Metastatic Castration-resistant Prostate Cancer Patients: A Population-based Study In Quebec
AUA 2017: Survival Among Female Urethral Cancer Patients 2004-2013, a National Cancer Database Analysis
AUA 2017: Changes in penile length after radical prostatectomy: Investigation of anatomical mechanism
AUA 2017: Survival Analysis of patients with T2 penile cancer who received inguinal lymph node dissection: Results from the National Cancer Database
AUA 2017: Oncological Outcomes And Patterns Of Recurrence Of Penile Sparing Approaches For Carcinoma Of The Penis: A Retrospective, Multicenter Cohort Analysis
AUA 2017: Identifying barriers to the adoption of percutaneous renal tumour biopsy in the management of small renal masses
AUA 2017: The nuclear grade and prognosis are unrelated to the TNM stage in multilocular cystic renal cell neoplasm of low malignant potential
AUA 2017: The Comprehensive Complication Index (CCI) is superior to the Clavien-Dindo grading system in predicting length of stay and hospital readmission following radical nephroureterectomy
AUA 2017: Utility of preoperative MRI in characterizing the parenchymal-tumor interface of renal masses prior to surgical intervention
AUA 2017: Prognostic Value of PD-1 and PD-L1 Expression in Patients with High-Grade Urothelial Carcinoma of the Upper Urinary Tract
AUA 2017: Molecular subtypes of muscle invasive bladder cancer are related to benefit from neoadjuvant chemotherapy: Development of a single sample patient assay
AUA 2017: The ERSPC Versus The ProtecT Study: Outcomes After Active Surveillance Compared to Surgery and Radiotherapy for Localized Prostate Cancer
AUA 2017: Stone Disease: Surgical Therapy VI
AUA 2017: Identifying the Optimal Candidate for Early Salvage Radiation Therapy after Radical Prostatectomy for Prostate Cancer: A Long-Term Multi-Institutional Analysis
AUA 2017: C-Reactive Protein and Erythrocyte Sedimentation Rate Predicts SIRS after Percutaneous Nephrolithotomy
AUA 2017: European Association of Urology (EAU) Lecture: Genomic Revolution in Bladder Cancer: Fast Approaching or a Distant Dream?
AUA 2017: Predicting Renal Cell Carcinoma Progression after Surgery
AUA 2017: Positive data from Phase 3 US Blue Light Cystoscopy with Cysview®
6
7
8
9
10
11
12
13
14
15
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free